Original Research Article
Year: 2020 | Month: March | Volume: 7 | Issue: 3 | Pages: 397-402
Invasive Extra-ovarian Recurrence in Borderline Ovarian Tumour: A Retrospective Analysis
Mahesh Rewadkar1, Roopa Balachandran2
1Associate Professor, 2Resident,
Department of Radiotherapy and Oncology, Govt. Cancer hospital, Aurangabad, Maharashtra, India,
Corresponding Author: Roopa Balachandran
ABSTRACT
Background: Borderline ovarian tumors (BOT) comprise up to 15–20% of ovarian epithelial neoplasms. Borderline ovarian tumors are histologically characterized as epithelial tumors with a stratified growth pattern but without destructive stromal invasion. Serous and mucinous neoplasms constitute the majority of borderline tumors and occur mostly in women of reproductive age.
Methodology: This is Multi-centric retrograde analytical study. We collected data from 2011-2019 of patients proven as Borderline Tumours of Ovary on Post-operative histopathology & Immunohistochemistry, who had frank invasive recurrence in the form extraovarian adenocarcinoma.
Results: In-total 22 out of 90 patients developed invasive extraovarian recurrence in the form of adenocarcinoma, with none of the patients had Supraclavicular Lymphadenopathy or lung/liver/brain/bone metastasis.
Conclusion: Since currently there is no convincing evidence that adjuvant chemotherapy or radiotherapy confers a survival advantage for patients of Borderline Ovarian Tumours of any stage. Long-term surveillance is recommended.
Keywords: Borderline ovarian tumour, invasive, serous, mucinous, adenocarcinoma
[PDF Full Text]